Creo Medical Group (STU:1RC) Change In Receivables : €-1.63 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Change In Receivables?

Creo Medical Group's change in receivables for the quarter that ended in Dec. 2023 was €0.46 Mil. It means Creo Medical Group's Accounts Receivable declined by €0.46 Mil from Jun. 2023 to Dec. 2023 .

Creo Medical Group's change in receivables for the fiscal year that ended in Dec. 2023 was €-1.63 Mil. It means Creo Medical Group's Accounts Receivable increased by €1.63 Mil from Dec. 2022 to Dec. 2023 .

Creo Medical Group's Accounts Receivable for the quarter that ended in Dec. 2023 was €7.43 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Creo Medical Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 77.35.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Creo Medical Group's liquidation value for the six months ended in Dec. 2023 was €12.25 Mil.

Creo Medical Group Change In Receivables Historical Data

The historical data trend for Creo Medical Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Change In Receivables Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.65

-0.44

-3.73

-1.84

-1.63

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial												-1.00	-3.50	1.61	-2.10	0.46

Creo Medical Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.63 Mil.

Creo Medical Group (STU:1RC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Creo Medical Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	7.429	/	17.527	*	91
=	77.35

2. In Ben Graham's calculation of liquidation value, Creo Medical Group's accounts receivable are only considered to be worth 75% of book value:

Creo Medical Group's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	21.474	-	19.501	+	0.75 * 7.429	+	0.5 * 9.402
=	12.25

Creo Medical Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (STU:1RC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (STU:1RC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CREO:UK

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (STU:1RC) Headlines

No Headlines